Chang-yue Gao

Daping, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

Effects of transcranial magnetic stimulation combined with extracorporeal shockwave therapy for poststroke spasticity: study protocol for a randomised controlled trial.

Effects of transcranial magnetic stimulation combined with extracorporeal shockwave therapy for poststroke spasticity: study protocol for a randomised controlled trial.

Journal: BMJ open
Published: January 03, 2025

Roles of blood monocytes carrying TREM2R47H mutation in pathogenesis of Alzheimer's disease and its therapeutic potential in APP/PS1 mice.

Roles of blood monocytes carrying TREM2R47H mutation in pathogenesis of Alzheimer's disease and its therapeutic potential in APP/PS1 mice.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: September 08, 2024

Intermittent Theta-Burst Stimulation for Stroke: Primary Motor Cortex Versus Cerebellar Stimulation: A Randomized Sham-Controlled Trial.

Intermittent Theta-Burst Stimulation for Stroke: Primary Motor Cortex Versus Cerebellar Stimulation: A Randomized Sham-Controlled Trial.

Journal: Stroke
Published: December 01, 2023

The long-term effects of intermittent theta burst stimulation on Alzheimer's disease-type pathologies in APP/PS1 mice.

The long-term effects of intermittent theta burst stimulation on Alzheimer's disease-type pathologies in APP/PS1 mice.

Journal: Brain research bulletin
Published: June 30, 2023

Intermittent Theta Burst Stimulation Attenuates Cognitive Deficits and Alzheimer's Disease-Type Pathologies via ISCA1-Mediated Mitochondrial Modulation in APP/PS1 Mice.

Intermittent Theta Burst Stimulation Attenuates Cognitive Deficits and Alzheimer's Disease-Type Pathologies via ISCA1-Mediated Mitochondrial Modulation in APP/PS1 Mice.

Journal: Neuroscience bulletin
Published: January 19, 2023

Prevalence and clinical predictors of spasticity after intracerebral hemorrhage.

Prevalence and clinical predictors of spasticity after intracerebral hemorrhage.

Journal: Brain and behavior
Published: April 14, 2022

p75NTR Ectodomain Ameliorates Cognitive Deficits and Pathologies in a Rapid Eye Movement Sleep Deprivation Mice Model.

p75NTR Ectodomain Ameliorates Cognitive Deficits and Pathologies in a Rapid Eye Movement Sleep Deprivation Mice Model.

Journal: Neuroscience
Published: February 25, 2022

Activation of Dopamine D2 Receptors Alleviates Neuronal Hyperexcitability in the Lateral Entorhinal Cortex via Inhibition of HCN Current in a Rat Model of Chronic Inflammatory Pain.

Activation of Dopamine D2 Receptors Alleviates Neuronal Hyperexcitability in the Lateral Entorhinal Cortex via Inhibition of HCN Current in a Rat Model of Chronic Inflammatory Pain.

Journal: Neuroscience bulletin
Published: October 31, 2021

Cysteine-Rich Repeat Domains 2 and 4 are Amyloid-β Binding Domains of Neurotrophin Receptor p75NTR and Potential Targets to Block Amyloid-β Neurotoxicity.

Cysteine-Rich Repeat Domains 2 and 4 are Amyloid-β Binding Domains of Neurotrophin Receptor p75NTR and Potential Targets to Block Amyloid-β Neurotoxicity.

Journal: Journal of Alzheimer's disease : JAD
Published: March 27, 2018

Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia.

Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia.

Journal: Journal of Alzheimer's disease : JAD
Published: December 28, 2017

Comorbidity Burden of Dementia: A Hospital-Based Retrospective Study from 2003 to 2012 in Seven Cities in China.

Comorbidity Burden of Dementia: A Hospital-Based Retrospective Study from 2003 to 2012 in Seven Cities in China.

Journal: Neuroscience bulletin
Published: October 16, 2017

The ProNGF/p75NTR pathway induces tau pathology and is a therapeutic target for FTLD-tau.

The ProNGF/p75NTR pathway induces tau pathology and is a therapeutic target for FTLD-tau.

Journal: Molecular psychiatry
Published: September 30, 2017
Showing 1-12 of 44

Last Updated: 09/26/2026